Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)

National Institutes of Health

Funding

Estimated total program funding: $650,000

About

The CTSA Collaborative and Innovative Acceleration Award (CCIA) aims to accelerate the pace of translational research by supporting the collaborative development, dissemination, and sustainable implementation of innovative solutions across the CTSA Program Consortium and beyond. This Notice of Funding Opportunity (NOFO) invites investigator-initiated applications to develop, demonstrate, and disseminate innovative new approaches, technologies, resources, or models that increase the impact of research across diseases, transform the field of translational science, and bring more treatments for all people more quickly.

Eligibility

Other Eligible Applicants include the following: See NOFO for further eligibility criteria. Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Applicant types

Grants.gov eligibility code 06

Visit Official Funding Page →

Continue researching

Related current grants

All Health & Medical grants →

Ending HIV and TB as public health threats through an accelerated and sustained comprehensive response in India

Centers for Disease Control-GHC

The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $6,000,000 for Year 1, subject to the availability of funds.This NOFO supports India"s National AIDS Control Organization (NACO), Central Tuberculosis Division (CTD), and other departmen

Trauma Care Readiness and Coordination Cooperative Agreement

Assistant Secretary for Preparedness and Response

A trauma system is, “…an organized, inclusive approach to facilitating and coordinating a multidisciplinary system response to severely injured patients.”[14] Coordination across prehospital entities (e.g., EMS) and hospitals signal an effective trauma system, where patients can ge

NCI Community Oncology Research Program (NCORP) Academic Community Sites (UG1 Clinical Trials Not Allowed)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) is one of three NOFOs for the National Cancer Institute (NCI) Community Oncology Research Program (NCORP). NCORP is designed to enhance generalizability and dissemination of clinical trial and other human subject research study results through accrual in a v

NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required)

National Institutes of Health

Notice-specific evidence check

What an applicant must verify for Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)

Applicant evidence

Applicant type: Public and state-controlled institutions of higher education

Opportunity boundaries

Recorded funding: Estimated total program funding: $650,000
Recorded deadline: October 20, 2027; confirm time zone and submission system.
Recorded focus: Health
Recorded focus: Information and statistics

Do not infer missing fields: geographic eligibility. Absence from this directory record is not evidence that a restriction does not exist.

Before investing in an application, connect every eligibility claim, required registration, submission component and deadline to the current official notice. Open the recorded official source →

Application checklist

How to apply for Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)

The steps below turn the recorded grant fields into a pre-submission check. They do not replace the current Notice of Funding Opportunity or its amendments.

Recorded eligibility

• Applicant types: Grants.gov eligibility code 06.
• Geographic scope is not structured in this record.
• Notice summary: Other Eligible Applicants include the following: See NOFO for further eligibility criteria. Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Focus areas: HL, ISS

Recorded deadline

October 19, 2027 — confirm the time zone and submission system

A missing or rolling date is not permission to assume an open application window.

1. Confirm fitMatch your applicant type, location, project scope and any cost-share or registration rule to the official notice.
2. Read the noticeCollect the current guidelines, amendments, budget rules, required attachments and submission instructions.
3. Check timingRecord the deadline time zone, internal review date and any earlier registration or portal cut-off.
4. Submit thereUse the official application route and save the confirmation or submission reference.

Official sources

Recorded source: https://www.grants.gov/xml-extract

Open official notice →

Last directory verification: Sep 13, 2026.